BCPC
Balchem CorpPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $74.3M | Q1 2026 | — |
| adjusted earnings from operations non-GAAP | $61M | Q1 2026 call | — |
| adjusted net earnings non-GAAP | $43M | Q1 2026 call | — |
| Free cash flow non-GAAP | $173.6M | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BCPC
this stock
Balchem Corp
|
$5.21B | +5.7% | +13.6% | 33.3 | 1.6% |
|
LIN
Linde PLC
|
$245.08B | +24.7% | +3.0% | 35.1 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$125.95B | +5.5% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$82.37B | +3.6% | +26.4% | 32.1 | 3.2% |
|
ECL
Ecolab Inc.
|
$77.20B | +4.8% | +2.2% | 37.1 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BCPC | -3.9% | -0.4% | -2.3% | -4.0% | +5.7% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -5.3% | -4.5% | -11.4% | -5.1% | -5.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.